Literature DB >> 29970494

Immune failure, infection and survival in chronic lymphocytic leukemia.

Kyle R Crassini1,2, O Giles Best3,2, Stephen P Mulligan3,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29970494      PMCID： PMC6029549          DOI： 10.3324/haematol.2018.196543

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Early stage chronic lymphocytic leukaemia carrying unmutated IGHV genes is at risk of recurrent infections during watch and wait.

Authors:  Davide Rossi; Lorenzo De Paoli; Francesca M Rossi; Michaela Cerri; Clara Deambrogi; Silvia Rasi; Antonella Zucchetto; Daniela Capello; Valter Gattei; Gianluca Gaidano
Journal:  Br J Haematol       Date:  2008-04-07       Impact factor: 6.998

2.  and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.

Authors:  Michael Asger Andersen; Casper Tabassum Eriksen; Christian Brieghel; Jorne Lionel Biccler; Caspar da Cunha-Bang; Marie Helleberg; Carsten Utoft Niemann
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

3.  Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia.

Authors:  Kyle R Crassini; Eva Zhang; Shalini Balendran; Jane A Freeman; O Giles Best; Cecily J Forsyth; Naomi J Mackinlay; Ping Han; William S Stevenson; Stephen P Mulligan
Journal:  Br J Haematol       Date:  2018-02-21       Impact factor: 6.998

4.  Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.

Authors:  Michael Asger Andersen; Fie Juhl Vojdeman; Mette Klarskov Andersen; Peter de Nully Brown; Christian Hartmann Geisler; Ole Weis Bjerrum; Carsten Utoft Niemann
Journal:  Leuk Lymphoma       Date:  2016-02-05

5.  The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.

Authors:  Sebastian Francis; Mamatha Karanth; Guy Pratt; Jane Starczynski; Laura Hooper; Chris Fegan; Chris Pepper; David Valcarcel; Donald W Milligan; Julio Delgado
Journal:  Cancer       Date:  2006-09-01       Impact factor: 6.860

Review 6.  Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment.

Authors:  S Molica
Journal:  Leuk Lymphoma       Date:  1994-04

Review 7.  Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.

Authors:  Vicki A Morrison
Journal:  Clin Lymphoma Myeloma       Date:  2009-10
  7 in total
  5 in total

1.  IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.

Authors:  Ganchimeg Ishdorj; Erin Streu; Pascal Lambert; Harbhajan S Dhaliwal; Salaheddin M Mahmud; Spencer B Gibson; Versha Banerji; Aaron J Marshall; James B Johnston
Journal:  Blood Adv       Date:  2019-07-23

2.  Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.

Authors:  Yandong Shen; Luke Coyle; Ian Kerridge; William Stevenson; Christopher Arthur; Naomi McKinlay; Keith Fay; Christopher Ward; Matthew Greenwood; Oliver Giles Best; Ann Solterbeck; Alexander Guminski; Stephen Shumack; Stephen P Mulligan
Journal:  EJHaem       Date:  2021-12-13

Review 3.  Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia.

Authors:  Yanyan Liu; Yongping Song; Qingsong Yin
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

4.  Machine learning can identify newly diagnosed patients with CLL at high risk of infection.

Authors:  Rudi Agius; Christian Brieghel; Michael A Andersen; Alexander T Pearson; Bruno Ledergerber; Alessandro Cozzi-Lepri; Yoram Louzoun; Christen L Andersen; Jacob Bergstedt; Jakob H von Stemann; Mette Jørgensen; Man-Hung Eric Tang; Magnus Fontes; Jasmin Bahlo; Carmen D Herling; Michael Hallek; Jens Lundgren; Cameron Ross MacPherson; Jan Larsen; Carsten U Niemann
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

Review 5.  Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy.

Authors:  Salvatrice Mancuso; Marta Mattana; Melania Carlisi; Marco Santoro; Sergio Siragusa
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.